EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares

Delisted

EBAC was delisted on the 2nd of March, 2023.

41 hedge funds and large institutions have $55.2M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$4.87M
2 +$2.2M
3 +$1.89M
4
CCM
CAAS Capital Management
New York
+$935K
5
GF
Gabelli Funds
New York
+$711K

Top Sellers

1 -$183K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$527K
27
$486K
28
$438K
29
$409K
30
$387K
31
$382K
32
$340K
33
$340K
34
$191K
35
$106K
36
$100K
37
$97K
38
$68K
39
$19K
40
$4K
41
$2K